Aelis Farma lists on Euronext Paris

Pier Vincenzo Piazza, co-founder and CEO of Aelis Farma, opens the trading day in Paris.

Aelis Farma is specialized in the research and development of drugs for the treatment of brain diseases.
The company has 2 products in clinical development, including AEF0117 for cannabis-related disorders (severe dependence, acute psychosis and acute toxicity), and AEF0217 for cognitive deficits (disorders related to Down syndrome, Fragile X syndrome, Subjective Memory Impairment (SMI) and Alzheimer's disease).